Posted by SLS on August 13, 2017, at 7:34:30
In reply to Re: People are taking NSI-189!?!?, posted by TriedEveryMedication on August 12, 2017, at 20:05:13
> I tried this. It didn't do much. Also it really did poorly recently in a phase II trial.
>
> "On July 25, 2017, Neuralstem announced results for the Phase 2 clinical trial of NSI-189 at 40 mg once daily and 40 mg twice daily indicated for MDD. The study compared the drug's performance to placebo and failed to meet its primary endpoint. As in previous trials, NSI-189 did not result in a statistically significant reduction in depression symptoms on the Montgomery-Asberg Depression Rating Scale (MADRS)."Damn.
Thanks for the information.
Maybe the drug is too pure a catecholamine reuptake inhibitor.
I haven't heard anything recently regarding the triple reuptake inhibitors.
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1094353
URL: http://www.dr-bob.org/babble/20161215/msgs/1094413.html